SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A.A. Martinez, M.G. Morgese, A. Pisanu, T. Macheda, M.A. Paquette, A. Seillier, T. Cassano, A.R. Carta, A. Giuffrida, Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats, Neurobiology of Disease, 2015, 74, 295

    CrossRef

  2. 2
    Janneth Gonzalez, Juan Camilo Jurado-Coronel, Marcos Fidel Ávila, Angélica Sabogal, Francisco Capani, George E. Barreto, NMDARs in neurological diseases: a potential therapeutic target, International Journal of Neuroscience, 2014, 140924103426003

    CrossRef

  3. 3
    Melanie A. Paquette, Alex A. Martinez, Teresa Macheda, Charles K. Meshul, Steven W. Johnson, S. Paul Berger, Andrea Giuffrida, Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors, European Journal of Neuroscience, 2012, 36, 9
  4. 4
    Behzad Elahi, Nicolás Phielipp, Robert Chen, N-Methyl-D-Aspartate Antagonists in Levodopa Induced Dyskinesia: A Meta-Analysis, The Canadian Journal of Neurological Sciences, 2012, 39, 04, 465

    CrossRef

  5. 5
    Edward C. Lauterbach, Leonardo F. Fontenelle, Antonio L. Teixeira, The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  6. 6
    S. Maranis, S. Tsouli, S. Konitsiotis, Treatment of motor symptoms in advanced Parkinson's disease: A practical approach, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011, 35, 8, 1795

    CrossRef

  7. 7
    Melanie A. Paquette, Akari M. Anderson, Jason R. Lewis, Charles K. Meshul, Steven W. Johnson, S. Paul Berger, MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism, Neuropharmacology, 2010, 58, 7, 1002

    CrossRef

  8. 8
    Kristin B. Dupre, Karen L. Eskow, Aimee Steiniger, Anna Klioueva, Giselle E. Negron, Lydia Lormand, John Y. Park, Christopher Bishop, Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat, Psychopharmacology, 2008, 199, 1, 99

    CrossRef

  9. 9
    G. Linazasoro, N. Van Blercom, L. Ugedo, J. A. Ruiz Ortega, Pharmacological treatment of Parkinson’s disease: life beyond dopamine D2/D3 receptors?, Journal of Neural Transmission, 2008, 115, 3, 431

    CrossRef

  10. 10
    Melanie A. Paquette, Elizabeth G. Brudney, Daniel B. Putterman, Charles K. Meshul, Steven W. Johnson, Stephen Paul Berger, Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias, NeuroReport, 2008, 19, 1, 111

    CrossRef

  11. 11
    Linda L. Werling, Edward C. Lauterbach, Ursula Calef, Dextromethorphan as a Potential Neuroprotective Agent With Unique Mechanisms of Action, The Neurologist, 2007, 13, 5, 272

    CrossRef

  12. 12
    Theresa A. Zesiewicz, Kelly L. Sullivan, Robert A. Hauser, Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment, Current Neurology and Neuroscience Reports, 2007, 7, 4, 302

    CrossRef

  13. 13
    Diego Centonze, Giorgio Bernardi, Giacomo Koch, Mechanisms of Disease: basic-research-driven investigations in humans—the case of hyperkinetic disorders, Nature Clinical Practice Neurology, 2007, 3, 10, 572

    CrossRef

  14. 14
    Spiridon Konitsiotis, Christos Tsironis, Dimitrios N. Kiortsis, Angelos Evangelou, Effects of N-methyl-d-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias, Psychopharmacology, 2006, 185, 3, 369

    CrossRef

  15. 15
    Jean-Francois Marier, Jean-Luc Deschênes, Amal Hage, Eleftheria Seliniotakis, Ari Gritsas, Themis Flarakos, Francis Beaudry, Pascal Vachon, Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil, Life Sciences, 2005, 77, 23, 2911

    CrossRef

  16. 16
    Spiros Konitsiotis, Novel pharmacological strategies for motor complications in Parkinson’s disease, Expert Opinion on Investigational Drugs, 2005, 14, 4, 377

    CrossRef

  17. 17
    R.H. Wessell, S.M. Ahmed, F.S. Menniti, G.L. Dunbar, T.N. Chase, J.D. Oh, NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats, Neuropharmacology, 2004, 47, 2, 184

    CrossRef

  18. 18
    Penelope J Hallett, David G Standaert, Rationale for and use of NMDA receptor antagonists in Parkinson's disease, Pharmacology & Therapeutics, 2004, 102, 2, 155

    CrossRef

  19. 19
    Gurutz Linazasoro, Recent failures of new potential symptomatic treatments for parkinson's disease: Causes and solutions, Movement Disorders, 2004, 19, 7
  20. 20
    Michael J Marino, Ornella Valenti, P Jeffrey Conn, Glutamate Receptors and Parkinson???s Disease, Drugs & Aging, 2003, 20, 5, 377

    CrossRef

  21. 21
    Carlo Colosimo, Alessandra Craus, Noradrenergic Drugs for Levodopa-Induced Dyskinesia, Clinical Neuropharmacology, 2003, 26, 6, 299

    CrossRef

  22. 22
    Thomas N. Chase, Francesco Bibbiani, Justin D. Oh, Striatal glutamatergic mechanisms and extrapyramidal movement disorders, Neurotoxicity Research, 2003, 5, 1-2, 139

    CrossRef

  23. 23
    Abdallah Hadj Tahar, Nancy Bélanger, Evelyne Bangassoro, Laurent Grégoire, Paul J Bédard, Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys, European Journal of Pharmacology, 2000, 399, 2-3, 183

    CrossRef

  24. 24
    L He, D.A Di Monte, J.W Langston, M Quik, Autoradiographic analysis of N-methyl-d-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Levodopa treatment, Neuroscience, 2000, 99, 4, 697

    CrossRef

  25. 25
    A.H. Ghodse, P.J. Bown, 2000,

    CrossRef

  26. 26
    A. Jiménez, C. Marin, M. Bonastre, E. Tolosa, Narrow beneficial effect of dextromethorphan on levodopa-induced motor response alterations in an experimental model of parkinsonism, Brain Research, 1999, 839, 1, 190

    CrossRef